Published 2 years ago • loading... • Updated 2 years ago

FDA to review preventative option for RSV in infants, developers say

Summary by Ground News

The FDA has accepted a biologics license application for a long-acting antibody. If approved, it could be available for use in some infants and toddlers later this year. AstraZeneca and Sanofi, which developed the therapy, say the FDA "has indicated it will work to expedite its review"

17 Articles

All

Left

Center

Right

WPBF

Center

FDA to review preventative option for RSV in infants, developers say

An antibody, administered as a single dose, is the first-of-its-kind to offer some protection against RSV for all infants in their first year of life.

2 years ago

Read Full Article

KOAT

Center

FDA to review preventative option for RSV in infants, developers say

The FDA has accepted a license application for a long-acting antibody for the prevention of lower respiratory tract infections caused by RSV.

2 years ago·Albuquerque, United States

Read Full Article

WAPT

Center

FDA to review preventative option for RSV in infants, developers say

An antibody, administered as a single dose, is the first-of-its-kind to offer some protection against RSV for all infants in their first year of life.

2 years ago·Jackson, United States

Read Full Article

WMTW

Center

FDA to review preventative option for RSV in infants, developers say

An antibody, administered as a single dose, is the first-of-its-kind to offer some protection against RSV for all infants in their first year of life.

2 years ago·Portland, United States

Read Full Article

WBAL-TV

Center

FDA to review preventative option for RSV in infants, developers say

An antibody, administered as a single dose, is the first-of-its-kind to offer some protection against RSV for all infants in their first year of life.

2 years ago·Baltimore, United States

Read Full Article

WISN

Center

FDA to review preventative option for RSV in infants, developers say

An antibody, administered as a single dose, is the first-of-its-kind to offer some protection against RSV for all infants in their first year of life.

2 years ago·Milwaukee, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year